Cornerstone Capital Management Holdings LLC. increased its stake in Humana Inc (NYSE:HUM) by 2.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 177,142 shares of the insurance provider’s stock after acquiring an additional 4,567 shares during the quarter. Cornerstone Capital Management Holdings LLC. owned approximately 0.13% of Humana worth $43,942,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of HUM. Nationwide Fund Advisors grew its holdings in shares of Humana by 0.4% in the 3rd quarter. Nationwide Fund Advisors now owns 170,587 shares of the insurance provider’s stock worth $41,560,000 after acquiring an additional 758 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Humana by 68.0% in the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 4,724 shares of the insurance provider’s stock worth $1,151,000 after acquiring an additional 1,912 shares during the last quarter. Gamco Investors INC. ET AL grew its holdings in shares of Humana by 71.5% in the 3rd quarter. Gamco Investors INC. ET AL now owns 8,875 shares of the insurance provider’s stock worth $2,162,000 after acquiring an additional 3,700 shares during the last quarter. Sei Investments Co. grew its holdings in shares of Humana by 97.7% in the 3rd quarter. Sei Investments Co. now owns 52,224 shares of the insurance provider’s stock worth $12,723,000 after acquiring an additional 25,808 shares during the last quarter. Finally, New York State Common Retirement Fund grew its holdings in shares of Humana by 1.1% in the 3rd quarter. New York State Common Retirement Fund now owns 379,800 shares of the insurance provider’s stock worth $92,531,000 after acquiring an additional 4,000 shares during the last quarter. Institutional investors and hedge funds own 97.85% of the company’s stock.
In related news, SVP Cynthia H. Zipperle sold 1,196 shares of Humana stock in a transaction on Friday, March 9th. The stock was sold at an average price of $273.33, for a total transaction of $326,902.68. Following the completion of the sale, the senior vice president now owns 7,771 shares of the company’s stock, valued at $2,124,047.43. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider M Todoroff Christopher sold 16,389 shares of Humana stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $273.37, for a total value of $4,480,260.93. Following the sale, the insider now directly owns 13,447 shares of the company’s stock, valued at approximately $3,676,006.39. The disclosure for this sale can be found here. In the last three months, insiders have sold 41,775 shares of company stock valued at $11,169,845. Insiders own 0.60% of the company’s stock.
Shares of Humana Inc (NYSE HUM) opened at $268.21 on Tuesday. The stock has a market capitalization of $37,518.98, a price-to-earnings ratio of 23.31, a P/E/G ratio of 1.48 and a beta of 0.95. Humana Inc has a 12-month low of $203.48 and a 12-month high of $293.35. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.48.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.00 by $0.06. The firm had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a return on equity of 16.13% and a net margin of 4.55%. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.34 earnings per share. equities analysts forecast that Humana Inc will post 13.81 EPS for the current year.
Humana announced that its Board of Directors has authorized a share repurchase program on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the insurance provider to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be given a dividend of $0.50 per share. This is a boost from Humana’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 0.75%. Humana’s dividend payout ratio (DPR) is presently 9.59%.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.